{"id":"doi:10.1016/j.canlet.2019.01.017","kind":"review","title":"CRISPR-Cas9 for cancer therapy: Opportunities and challenges","authors":["Minjiang Chen","Aiwu Mao","Min Xu","Qiaoyou Weng","Jianting Mao","Jiansong Ji"],"author_count":6,"year":2019,"published":"2019-01-24","venue":"Cancer Letters","cited_by":272,"doi":"10.1016/j.canlet.2019.01.017","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.canlet.2019.01.017","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.canlet.2019.01.017","updated":null,"pmid":"30684591","pmcid":null,"openalex_id":"W2912664742","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["CRISPR and Genetic Engineering"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}